EFFICACY AND TOLERABILITY OF NIMESULIDE IN ELDERLY PATIENTS WITH OSTEO-ARTHRITIS - DOUBLE-BLIND TRIAL VERSUS NAPROXEN

被引：23
|
作者：
FOSSALUZZA, V
MONTAGNANI, G
机构：
[1] LPB IST FARMACEUT SPA,DEPT MED,VIA LAVORATORI 54,I-20092 MILAN,ITALY
[2] CITY HOSP,DEPT MED 4,UDINE,ITALY
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1989年 / 17卷 / 03期
关键词：
D O I：
10.1177/030006058901700313
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：295 / 303
页数：9
相关论文
共 50 条
  • [31] CONTROLLED-RELEASE NAPROXEN COMPARED WITH ISOXICAM IN PATIENTS WITH OSTEO-ARTHRITIS
    FRANKHOF, W
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1988, 11 (01) : 28 - 33
  • [32] MULTICENTER DOUBLE-BLIND COMPARISON OF SUSTAINED ACTION FORMULATIONS OF TIAPROFENIC ACID AND INDOMETHACIN IN OSTEO-ARTHRITIS
    CALIN, A
    CAWLEY, MID
    PAL, B
    ROSENBERG, JN
    SILAS, AM
    WILLIAMS, PI
    [J]. DRUGS, 1988, 35 : 57 - 63
  • [33] DOUBLE-BLIND MULTICENTER STUDY OF THE ACTIVITY OF S-ADENOSYLMETHIONINE IN HIP AND KNEE OSTEO-ARTHRITIS
    GLORIOSO, S
    TODESCO, S
    MAZZI, A
    MARCOLONGO, R
    GIORDANO, M
    COLOMBO, B
    CHERIELIGNIERE, G
    MATTARA, L
    LEARDINI, G
    PASSERI, M
    CUCINOTTA, D
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1985, 5 (01) : 39 - 49
  • [34] SODIUM MECLOFENAMATE IN HIP AND KNEE OSTEO-ARTHRITIS - 2 DOUBLE-BLIND STUDIES WITH PLACEBO CONTROL
    VREEDE, PV
    BARAGAR, FD
    [J]. INVESTIGACION MEDICA INTERNACIONAL, 1981, 8 (04): : 341 - 349
  • [35] DOUBLE-BLIND PREFERENCE AND COMPLIANCE MULTICENTER STUDY IN OSTEO-ARTHRITIS - ONCE-A-DAY TREATMENT
    MARCOLONGO, R
    GIORDANO, N
    BASSI, GP
    GIANNINI, R
    BORGHI, C
    FRANCUCCI, BM
    CAMARRI, E
    MORDINI, M
    COCCO, F
    NERI, D
    GORETTI, P
    ROSSI, R
    MEONI, S
    PESCATORI, P
    RUBEGNI, M
    PROVEDI, D
    [J]. CLINICAL RHEUMATOLOGY, 1985, 4 (03) : 267 - 277
  • [36] EFFICACY AND TOLERABILITY OF ENTERIC-COATED NAPROXEN IN THE TREATMENT OF OSTEOARTHRITIS AND RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND COMPARISON WITH STANDARD NAPROXEN FOLLOWED BY AN OPEN-LABEL TRIAL
    BELLAMY, N
    BEAULIEU, A
    BOMBARDIER, C
    HUANG, S
    KRAAG, G
    MENARD, HA
    RUSSELL, AS
    TANNENBAUM, H
    WILLANS, M
    CAMPBELL, J
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1992, 12 (10) : 640 - 651
  • [37] Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - A double-blind trial
    Yocum, DE
    Furst, DE
    Kaine, JL
    Baldassare, AR
    Stevenson, JT
    Borton, MA
    Mengle-Gaw, LJ
    Schwartz, BD
    Wisemandle, W
    Mekki, QA
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3328 - 3337
  • [38] NIMESULIDE IN THE TREATMENT OF ADVANCED CANCER PAIN - DOUBLE-BLIND COMPARISON WITH NAPROXEN
    GALLUCCI, M
    TOSCANI, F
    MAPELLI, A
    CANTARELLI, A
    VECA, G
    SCARICABAROZZI, I
    [J]. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (08): : 1028 - 1030
  • [39] MULTICENTRIC CLINICAL-TRIAL WITH 500 MG BID OF NAPROXEN IN THE TREATMENT OF 172 PATIENTS WITH OSTEO-ARTHRITIS
    FAILLA, V
    CAMPOS, BDS
    DOSSANTOS, LTMF
    MELO, DLPM
    MENDOZA, LEL
    DEOLIVEIRA, LGD
    HAMACHER, PG
    DEMELLO, NJR
    GOVONI, MMVB
    [J]. REVISTA BRASILEIRA DE MEDICINA, 1988, 45 (03) : 78 - 83
  • [40] A DOUBLE-BLIND, PARALLEL TRIAL OF OXAPROZIN VERSUS NAPROXEN IN THE TREATMENT OF OSTEOARTHRITIS
    GINSBERG, F
    FAMAEY, JP
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1984, 8 (10) : 689 - 695
12345